Literature DB >> 2400967

Steroid-hormone receptors in nonpalpable and more advanced stages of breast cancer. A contribution to the biology and natural history of carcinoma of the female breast.

J G Tinnemans1, L V Beex, T Wobbes, R F Sluis, J M Raemaekers, T Benraad.   

Abstract

Tumors of five groups of patients, with (1) nonpalpable primary breast cancer, (2) palpable operable primary breast cancer, (3) loco-regionally advanced primary breast cancer, (4) first and (5) late metastatic breast cancer, were studied in respect to their steroid receptor content. A statistically significant decrease of progesterone receptor positive tumors and of tumors positive for estradiol and progesterone receptors, was found with increasing advance of the disease. A reversed extrapolation of these figures supports the hypothesis that every breast cancer contains steroid receptors and is hormone-dependent from its inception.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2400967     DOI: 10.1002/1097-0142(19900915)66:6<1165::aid-cncr2820660615>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Tamoxifen resistance in breast cancer: elucidating mechanisms.

Authors:  L C Dorssers; S Van der Flier; A Brinkman; T van Agthoven; J Veldscholte; E M Berns; J G Klijn; L V Beex; J A Foekens
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group.

Authors:  P G Koenders; L V Beex; R Langens; P W Kloppenborg; A G Smals; T J Benraad
Journal:  Breast Cancer Res Treat       Date:  1991-03       Impact factor: 4.872

3.  Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States).

Authors:  C Schairer; C Byrne; P M Keyl; L A Brinton; S R Sturgeon; R N Hoover
Journal:  Cancer Causes Control       Date:  1994-11       Impact factor: 2.506

4.  Human breast cancer: survival from first metastasis. Breast Cancer Study Group.

Authors:  P G Koenders; L V Beex; P W Kloppenborg; A G Smals; T J Benraad
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer.

Authors:  C J Fabian; C Zalles; S Kamel; B F Kimler; R McKittrick; A S Tranin; S Zeiger; W P Moore; R S Hassanein; C Simon
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  Immunohistochemical and other features of breast carcinomas presenting clinically compared with those detected by cancer screening.

Authors:  W K Cowan; B Angus; J Henry; I P Corbett; W A Reid; C H Horne
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.